A61K 38/1722
Plasma globulins, lactoglobulins
Official title: {Plasma globulins, lactoglobulins}
A61K38/1722 (Plasma globulins, lactoglobulins) appears on 42 US grants and 101 published applications in this corpus.
Search patents in A61K- Granted patents
- 42
- Published applications
- 101
- Assignees
- 67
- Inventors
- 207
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 2 |
| 2011 | 0 | 1 |
| 2012 | 0 | 3 |
| 2013 | 2 | 3 |
| 2014 | 3 | 3 |
| 2015 | 1 | 7 |
| 2016 | 3 | 7 |
| 2017 | 2 | 5 |
| 2018 | 3 | 7 |
| 2019 | 5 | 9 |
| 2020 | 5 | 4 |
| 2021 | 5 | 12 |
| 2022 | 3 | 12 |
| 2023 | 5 | 4 |
| 2024 | 1 | 5 |
| 2025 | 1 | 8 |
| 2026 | 1 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Insulinotropic and glucagonotropic effects of beta-lactoglobulin24 Feb 2026US 12,558,401 B2Arla Foods Amba
- Method of reducing titers of antibodies specific for a therapeutic agent6 May 2025US 12,290,549 B2Duke University
- Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants20 Aug 2024US 12,064,452 B2Duke University
- System and method for isolating alpha 2M molecules5 Dec 2023US 11,833,279 B2Astaria Global, LLC
- ApoC-II mimetic peptides28 Nov 2023US 11,827,690 B2Novo Nordisk
- Insulinotropic and glucagonotropic effects of beta-lactoglobulin27 Aug 2026US 2026/0248884 A1
- Pharmaceutical compositions comprising protein complexes13 Aug 2026US 2026/0232818 A1Onchilles Pharma, Inc.
- Therapeutic protein combinations30 Jul 2026US 2026/0216286 A1Ohio State Innovation Foundation
- Gc-globulin for use in treating diabetes9 Apr 2026US 2026/0098068 A1
- Haptoglobulin for Use in Treating or Preventing Exaggerated Erectile Response or Erectile Dysfunction12 Mar 2026US 2026/0069657 A1CSL Behring GmbH
Most cited
By later US patents
- Composition and method for dermal and transdermal administration of a cytokine29US 6,165,458 APharmaDerm Laboratories Ltd. · 2000
- Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products15US 10,357,513 B2Alkahest, Inc. · 2019
- Systems, compositions, and methods for transplantation and treating conditions14US 9,352,021 B2Cytonics Corporation · 2016
- Treatment of conditions related to cecal ligation shock11US 8,541,371 B2The Regents of the University of California · 2013
- Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders10US 8,354,370 B2Garnet BioTherapeutics, Inc. · 2013